Document is current
Any future updates will be listed below
-
Authors
Kabani, Aamna
Lenihan, Victoria F.
Zhang, Christiana
Berger, Zackary D.
Pollack, Craig E.
Eaton, Cyd K.
Liu, Yisi
Dy, Sydney M.
Peairs, Kimberly S.
Choi, Youngjee
-
Funding
Funding for this research was provided by:
Merck Company Foundation (NO22890, NO22890)
- License Information
-
More Information
Article History
Received: 30 November 2022
Accepted: 5 April 2023
First Online: 24 April 2023
Declarations
:
: Drs. Choi and Peairs have received salary support from a Merck Foundation Grant. Dr. Pollack reports stock ownership in Gilead Pharmaceuticals. The remaining authors have no conflicts of interest to report.
